Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Assertio Holdings, Inc. (ASRT : NSDQ)
 
 • Company Description   
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.

Number of Employees: 58

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.71 Daily Weekly Monthly
20 Day Moving Average: 227,546 shares
Shares Outstanding: 95.78 (millions)
Market Capitalization: $68.01 (millions)
Beta: 0.29
52 Week High: $1.80
52 Week Low: $0.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 15.11% 10.80%
12 Week 16.33% -2.15%
Year To Date -18.48% -23.66%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 S. Saunders Road Suite 300
-
Lake Forest,IL 60045
USA		 ph: 224-419-7106
fax: 510-744-8001		 investor@assertiotx.com http://www.assertiotx.com
 
 • General Corporate Information   
Officers
Brendan P. O'Grady - Chief Executive Officer and Director
Heather L. Mason - Chairman
Ajay Patel - Chief Financial Officer
Sravan Emany - Director
Sigurd C. Kirk - Director

Peer Information
Assertio Holdings, Inc. (GSAC)
Assertio Holdings, Inc. (CASI)
Assertio Holdings, Inc. (ALCD.)
Assertio Holdings, Inc. (OMNN)
Assertio Holdings, Inc. (CGPI.)
Assertio Holdings, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 04546C205
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 95.78
Most Recent Split Date: 5.00 (0.25:1)
Beta: 0.29
Market Capitalization: $68.01 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.22 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 10.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.63
Price/Cash Flow: 14.47
Price / Sales: 0.57
EPS Growth
vs. Year Ago Period: -566.67%
vs. Previous Quarter: -27.27%
Sales Growth
vs. Year Ago Period: -18.37%
vs. Previous Quarter: -17.69%
ROE
06/30/25 - -
03/31/25 - -24.87
12/31/24 - -11.03
ROA
06/30/25 - -
03/31/25 - -10.87
12/31/24 - -5.09
Current Ratio
06/30/25 - -
03/31/25 - 1.66
12/31/24 - 1.77
Quick Ratio
06/30/25 - -
03/31/25 - 1.35
12/31/24 - 1.43
Operating Margin
06/30/25 - -
03/31/25 - -25.72
12/31/24 - -11.43
Net Margin
06/30/25 - -
03/31/25 - -25.72
12/31/24 - -17.27
Pre-Tax Margin
06/30/25 - -
03/31/25 - -25.59
12/31/24 - -17.23
Book Value
06/30/25 - -
03/31/25 - 1.13
12/31/24 - 1.27
Inventory Turnover
06/30/25 - -
03/31/25 - 0.92
12/31/24 - 1.01
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.36
12/31/24 - 0.32
Debt-to-Capital
06/30/25 - -
03/31/25 - 26.40
12/31/24 - 24.27
 

Powered by Zacks Investment Research ©